Skip to main content

Table 3 Multivariable analyses in the TMA cohort

From: The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation

Covariates

OS

HR (95% CI)

P

UCHL1 expression

0.738 (0.535–1.018)

0.064

Age (< >  18 months)

1.508 (0.548–4.155)

0.427

Stage (4, 4S vs 1, 2, 3)

1.619 (0.674–3.891)

0.281